Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 15.4B | 14.2B | 13.8B | 13.5B |
| Cost of revenue | 13.7B | 12.3B | 12.0B | 11.8B |
| Gross profit | 1.7B | 1.9B | 1.7B | 1.7B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 60M | 60M | 61M | 57M |
| Other operating expenses | — | — | — | — |
| Operating income | 1.7B | 1.9B | 1.7B | 1.7B |
| Non operating interest income | ||||
| Income | 9M | 17M | 16M | 5M |
| Expense | 341M | 347M | 345M | 333M |
| Other income expense | 95M | 108M | 99M | 101M |
| Pretax income | 1.4B | 1.6B | 1.5B | 1.4B |
| Tax provision | 24M | 10M | 19M | 15M |
| Net income | 1.4B | 1.6B | 1.4B | 1.4B |
| Basic EPS | 0.6 | 0.7 | 0.7 | 0.6 |
| Diluted EPS | 0.6 | 0.7 | 0.7 | 0.6 |
| Basic average shares | 2.2B | 2.2B | 2.2B | 2.2B |
| Diluted average shares | 2.2B | 2.2B | 2.2B | 2.2B |
| EBITDA | 2.3B | 2.6B | 2.3B | 2.3B |
| Net income from continuing op. | 1.4B | 1.6B | 1.4B | 1.4B |
| Minority interests | -12M | -13M | -14M | -16M |
| Preferred stock dividends | 13M | — | — | 13M |